C4X Discovery Holdings plc – LSE:C4XD.L
C4X Discovery Holdings stock price today
C4X Discovery Holdings stock price monthly change
C4X Discovery Holdings stock price quarterly change
C4X Discovery Holdings stock price yearly change
C4X Discovery Holdings key metrics
Market Cap | 30.26M |
Enterprise value | 861.71M |
P/E | -3.72 |
EV/Sales | 487.94 |
EV/EBITDA | -80.85 |
Price/Sales | 5.00 |
Price/Book | 0.74 |
PEG ratio | 0.03 |
EPS | 0.01 |
Revenue | 28.98M |
EBITDA | -121.99K |
Income | 3.04M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -479.49% |
Oper. margin | -615.01% |
Gross margin | 100% |
EBIT margin | -615.01% |
EBITDA margin | -0.42% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeC4X Discovery Holdings stock price history
C4X Discovery Holdings stock forecast
C4X Discovery Holdings financial statements
| Jul 2022 | 2.63M | -3.64M | -138.36% |
|---|---|---|---|
| Jan 2023 | 1.67M | -3.87M | -231.44% |
| Jul 2023 | 34K | -7.23M | -21270.59% |
| Jan 2024 | 24.64M | 17.79M | 72.21% |
| 2026 | 8.10M | -5.4M | -66.58% |
|---|
Analysts Price target
Financials & Ratios estimates
| Jul 2022 | 14582000 | 2.77M | 19.05% |
|---|---|---|---|
| Jan 2023 | 15727000 | 2.17M | 13.82% |
| Jul 2023 | 8784000 | 2.25M | 25.64% |
| Jan 2024 | 26223000 | 1.61M | 6.17% |
| Jul 2022 | -6.47M | -27K | -97K |
|---|---|---|---|
| Jan 2023 | -688K | -8K | 5.25M |
| Jul 2023 | -5.31M | -10K | -174K |
| Jan 2024 | 9.08M | -10K | -169K |
C4X Discovery Holdings alternative data
| Aug 2023 | 48 |
|---|---|
| Sep 2023 | 48 |
| Oct 2023 | 48 |
| Nov 2023 | 48 |
| Dec 2023 | 48 |
| Jan 2024 | 49 |
| Feb 2024 | 49 |
| Mar 2024 | 49 |
| Apr 2024 | 49 |
| May 2024 | 49 |
| Jun 2024 | 49 |
| Jul 2024 | 49 |
C4X Discovery Holdings other data
| Insider | Compensation |
|---|---|
Mr. Bradley Richard Hoy (1963) Chief Financial Officer, Sec. & Director | $196,000 |
Dr. Clive James Dix (1955) Chief Executive Officer & Director | $194,000 |
-
What's the price of C4X Discovery Holdings stock today?
One share of C4X Discovery Holdings stock can currently be purchased for approximately $42.5.
-
When is C4X Discovery Holdings's next earnings date?
Unfortunately, C4X Discovery Holdings's (C4XD.L) next earnings date is currently unknown.
-
Does C4X Discovery Holdings pay dividends?
No, C4X Discovery Holdings does not pay dividends.
-
How much money does C4X Discovery Holdings make?
C4X Discovery Holdings has a market capitalization of 30.26M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 36.64% to 1.71M US dollars.
-
What is C4X Discovery Holdings's stock symbol?
C4X Discovery Holdings plc is traded on the LSE under the ticker symbol "C4XD.L".
-
What is C4X Discovery Holdings's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of C4X Discovery Holdings?
Shares of C4X Discovery Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are C4X Discovery Holdings's key executives?
C4X Discovery Holdings's management team includes the following people:
- Mr. Bradley Richard Hoy Chief Financial Officer, Sec. & Director(age: 62, pay: $196,000)
- Dr. Clive James Dix Chief Executive Officer & Director(age: 70, pay: $194,000)
-
How many employees does C4X Discovery Holdings have?
As Jul 2024, C4X Discovery Holdings employs 49 workers.
-
When C4X Discovery Holdings went public?
C4X Discovery Holdings plc is publicly traded company for more then 10 years since IPO on 23 Oct 2014.
-
What is C4X Discovery Holdings's official website?
The official website for C4X Discovery Holdings is c4xdiscovery.com.
-
How can i contact C4X Discovery Holdings?
C4X Discovery Holdings can be reached via phone at +44 161 235 5085.
C4X Discovery Holdings company profile:
C4X Discovery Holdings plc
c4xdiscovery.comLSE
49
Biotechnology
Healthcare
C4X Discovery Holdings plc operates as a drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality. The company's product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation and autoimmune diseases; a4Ăź7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. It has partnerships with Sanofi, GEN-COVID, LifeArc, Indivior PLC, Phoremost, AstraZeneca UK Limited, and Evotec SE. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.
Manchester, M1 3LD
:
ISIN: GB00BQQ2RV18
:
